EMEA-000184-PIP03-16

Key facts

Invented name
Tobi Podhaler
Active substance
Tobramycin
Therapeutic area
Infectious diseases
Decision number
P/0114/2017
PIP number
EMEA-000184-PIP03-16
Pharmaceutical form(s)
  • Inhalation powder
  • Capsule, hard
Condition(s) / indication(s)
Treatment of Pseudomonas aeruginosa pulmonary colonisation in patients with bronchiectasis
Route(s) of administration
Inhalation use
Contact for public enquiries
Novartis Europharm Limited
Switzerland
E-mail: paediatric.enquiries@novartis.com
Tel.: +41 623241111
Fax: +41 613248001
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating